chinese_flag_beijing_-_img_1104

China to establish national rare disease network

pharmafile | February 19, 2019 | News story | Manufacturing and Production China, NHC, healthcare, rare diseases 

China is set to establish a national collaborative network of hospitals for rare disease diagnosis and treatment to promote early detection and effective treatment of rare diseases.

The initiative, announced by the National Health Commission, will see 324 hospitals, chosen for their capacity and experience in treating patients with rare disease, participate in the network.

The network will facilitate the timely transfer of difficult and complicated cases between hospitals and the allocation of quality medical resources for patients.

Meanwhile hospitals will be urged to further train doctors and medical workers in dealing with rare diseases with a focus on improving doctor’s abilities to make diagnoses.    

The decision comes after the Chinese government cut VAT on 21 drugs for rare diseases causing stocks in Chinese pharmaceutical companies to soar.

Louis Goss

Related Content

AstraZeneca to acquire Amolyt Pharma for up to $1.05bn

AstraZeneca has announced that it has entered into a definitive agreement under which it will …

AstraZeneca and Sanofi’s Beyfortus approved in China

AstraZeneca and Sanofi have announced that Beyfortus (nirsevimab) has been approved in China for the …

First patient enrolled in Boan Biotech’s phase 3 trial for Nivolumab in China

Boan Biotech has announced that the first patient has been enrolled in its phase 3 …

Latest content